521 related articles for article (PubMed ID: 35163820)
21. Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides.
Lee W; Ha JM; Sugiyama Y
J Biol Chem; 2020 Dec; 295(50):17349-17364. PubMed ID: 33051208
[TBL] [Abstract][Full Text] [Related]
22. Overview of SLC22A and SLCO families of drug uptake transporters in the context of cancer treatments.
Cutler MJ; Choo EF
Curr Drug Metab; 2011 Oct; 12(8):793-807. PubMed ID: 21787263
[TBL] [Abstract][Full Text] [Related]
23. Oatp58Dc contributes to blood-brain barrier function by excluding organic anions from the Drosophila brain.
Seabrooke S; O'Donnell MJ
Am J Physiol Cell Physiol; 2013 Sep; 305(5):C558-67. PubMed ID: 23804204
[TBL] [Abstract][Full Text] [Related]
24. The blood-brain barrier choline transporter.
Geldenhuys WJ; Allen DD
Cent Nerv Syst Agents Med Chem; 2012 Jun; 12(2):95-9. PubMed ID: 22483271
[TBL] [Abstract][Full Text] [Related]
25. Organic Cation Transporter (OCT/OCTN) Expression at Brain Barrier Sites: Focus on CNS Drug Delivery.
Betterton RD; Davis TP; Ronaldson PT
Handb Exp Pharmacol; 2021; 266():301-328. PubMed ID: 33674914
[TBL] [Abstract][Full Text] [Related]
26. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.
Ose A; Kusuhara H; Endo C; Tohyama K; Miyajima M; Kitamura S; Sugiyama Y
Drug Metab Dispos; 2010 Jan; 38(1):168-76. PubMed ID: 19833843
[TBL] [Abstract][Full Text] [Related]
27. Functional Expression of Organic Anion Transporting Polypeptide 1a4 Is Regulated by Transforming Growth Factor-
Abdullahi W; Brzica H; Hirsch NA; Reilly BG; Ronaldson PT
Mol Pharmacol; 2018 Dec; 94(6):1321-1333. PubMed ID: 30262595
[TBL] [Abstract][Full Text] [Related]
28. Uptake Transporters at the Blood-Brain Barrier and Their Role in Brain Drug Disposition.
Parvez MM; Sadighi A; Ahn Y; Keller SF; Enoru JO
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896233
[TBL] [Abstract][Full Text] [Related]
29. Organic Cation Transporter Expression and Function in the CNS.
Sweet DH
Handb Exp Pharmacol; 2021; 266():41-80. PubMed ID: 33963461
[TBL] [Abstract][Full Text] [Related]
30. Organic Anion-Transporting Polypeptide 1a4 (Oatp1a4/Slco1a4) at the Blood-Arachnoid Barrier is the Major Pathway of Sulforhodamine-101 Clearance from Cerebrospinal Fluid of Rats.
Yaguchi Y; Tachikawa M; Zhang Z; Terasaki T
Mol Pharm; 2019 May; 16(5):2021-2027. PubMed ID: 30977661
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
[TBL] [Abstract][Full Text] [Related]
32. Highlights From the American Association of Pharmaceutical Scientists/ International Transporter Consortium Joint Workshop on Drug Transporters in Absorption, Distribution, Metabolism, and Excretion: From the Bench to the Bedside - Clinical Pharmacology Considerations.
Ronaldson PT; Bauer B; El-Kattan AF; Shen H; Salphati L; Louie SW
Clin Pharmacol Ther; 2016 Nov; 100(5):419-422. PubMed ID: 27500791
[TBL] [Abstract][Full Text] [Related]
33. Drug delivery to the ischemic brain.
Thompson BJ; Ronaldson PT
Adv Pharmacol; 2014; 71():165-202. PubMed ID: 25307217
[TBL] [Abstract][Full Text] [Related]
34. Functional Investigation of Solute Carrier Family 35, Member F2, in Three Cellular Models of the Primate Blood-Brain Barrier.
Mochizuki T; Mizuno T; Kurosawa T; Yamaguchi T; Higuchi K; Tega Y; Nozaki Y; Kawabata K; Deguchi Y; Kusuhara H
Drug Metab Dispos; 2021 Jan; 49(1):3-11. PubMed ID: 33144341
[TBL] [Abstract][Full Text] [Related]
35. Nanomedicinal Strategies as Emerging Therapeutic Avenues to Treat and Manage Cerebral Ischemia.
Fatima S; Quadri SN; Parveen S; Beg S; Barkat MA; Samim M; Abdin MZ; Ahmad FJ
CNS Neurol Disord Drug Targets; 2021; 20(2):125-144. PubMed ID: 33138766
[TBL] [Abstract][Full Text] [Related]
36. P-glycoprotein, breast cancer resistance protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during blood-brain barrier maturation: involvement of Wnt/β-catenin and endothelin-1 signaling.
Harati R; Benech H; Villégier AS; Mabondzo A
Mol Pharm; 2013 May; 10(5):1566-80. PubMed ID: 22998451
[TBL] [Abstract][Full Text] [Related]
37. Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice.
Miyajima M; Kusuhara H; Fujishima M; Adachi Y; Sugiyama Y
Drug Metab Dispos; 2011 May; 39(5):814-9. PubMed ID: 21325432
[TBL] [Abstract][Full Text] [Related]
38. The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail.
Ebner T; Ishiguro N; Taub ME
J Pharm Sci; 2015 Sep; 104(9):3220-8. PubMed ID: 25981193
[TBL] [Abstract][Full Text] [Related]
39. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
[TBL] [Abstract][Full Text] [Related]
40. Organic anion-transporting polypeptides at the blood-brain and blood-cerebrospinal fluid barriers.
Westholm DE; Rumbley JN; Salo DR; Rich TP; Anderson GW
Curr Top Dev Biol; 2008; 80():135-70. PubMed ID: 17950374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
